|Vaso Corporation -- USA Stock|| |
USD 0.0796 0.0004 0.5%
Sr. VP, Director and CEO of Vasohealthcare
Mr. Randy Hill was appointed as Director of Vasomedical Inc
Age: 67 CEO Since 2013
Hill joined the Company as Senior Vice President of Vasomedical and Chief Executive Officer of Vaso Diagnostics, Inc. d/b/a/ VasoHealthcare, a wholly owned subsidiary of Vasomedical, on July 30, 2012. Prior to joining Vasomedical, Mr. Hill was, until May 2011, interim Chief Executive Officer of Siemens Healthcare USA, the U.S. organization of the healthcare sector of Siemens AG, a German multinational conglomerate, where he was responsible for sales, marketing, service, and logistics across the Siemens Healthcare portfolio. For several years prior thereto, Mr. Hill was Chief Operating Officer of Siemens Healthcare USA, responsible for setting and implementing national strategies to sell Siemens products and services, and achieving synchronization across Siemens Healthcare?s U.S. Business Management and Solutions Implementation teams.
The company has return on total asset (ROA)
of (1.7) %
which means that it has lost $1.7 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (21.69) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 9.23 M in liabilities with Debt to Equity (D/E) ratio of 90.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vaso Corporation has Current Ratio of 0.79 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
Vasomedical, Inc. operates in the healthcare equipment and information technology industries. Vaso Corporation (VASO) is traded on OTC Market in USA. It is located in NEW YORK, U.S.A and employs 281 people. Vaso is listed under Medical Equipment category by Fama And French industry classification.